EU GMP Annex 11: What’s Changing in the 2025 Draft Concept Paper?
While paper trails and legacy systems remain part of the landscape, pharma has been actively coding its next chapter: evolving through digital innovation, transforming core functions like drug development, manufacturing, regulatory oversight, and patient interaction. Central to this is the adoption of advanced technologies such as artificial intelligence (AI), blockchain, cloud computing, and digital twins, […]

